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Abstract
We describe a unique flow cytometer (TDI-SFC) for the immunophenotyping of low-abundance 
cells, particularly when cell counts are sample-limited and operationally difficult for analysis by 
fluorescence microscopy (>100 cells) or multiparameter flow cytometry (MFC, <10 000 cells). 
TDI-SFC combines the high spectral resolution of spectral flow cytometry (SFC) with a CCD 
operated in time-delayed integration (TDI) for improved duty cycle and sensitivity. Cells were 
focused with a 1D-sheathing microfluidic device, and fluorescence emission generated from a 488 
nm laser was collected by epi-illumination and dispersed along one axis of a CCD by a 
spectrograph. Along the other axis, the CCD’s shift rate was clocked at a rate that closely matched 
the cells’ velocity through the field of view. This TDI-SFC format allowed the CCD shutter to 
remain open during signal acquisition, providing a duty cycle ~100% and assurance that ~95% 
cells were interrogated. We used fluorescent beads to optimize synchronization of TDI clocking 
with the sheathed-cell velocity and to improve sensitivity via the excitation intensity, epi-
illumination numerical aperture, and integration time. TDI achieved integrated signals of 106 
counts at a signal-to-noise ratio (SNR) of 610 for beads corresponding to a load of 4 × 105 
antibodies. We also evaluated multiplexing capabilities by spectral deconvolution and undertook a 
proof-of-concept application to immunophenotype low-abundance cells; the demonstration 
consisted of immunophenotyping a model cell line, in this case SUP-B15 cells representing B-cell 
acute lymphoblastic leukemia (B-ALL). The B-ALL cell line was stained against a leukemic 
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marker (terminal deoxynucleotidyl transferase, TdT), and we successfully used spectral unmixing 
to discriminate TdT(+) cells from TdT(−) cells even at low cell counts (~100 cells). The TDI-SFC 
could potentially be used in any application requiring the immunophenotyping of low-abundance 
cells, such as in monitoring measurable residual disease in acute leukemias following affinity 
enrichment of circulating leukemia cells from peripheral blood.
Graphical Abstract
Multiparameter flow cytometry (MFC) is used to characterize biological cells for size, 
granularity, and protein expression as well as other cellular characteristics. MFCs typically 
use sheath flow to hydrodynamically align immunolabeled cells into a single-file line 
through excitation laser beams. Optical-bandpass filters spectrally sort fluorescence into 
relatively wide wavelength ranges (channels) that are transduced by photomultiplier tubes 
(PMTs). Modern MFCs can analyze 104 to 105 cells per second across several fluorescence 
channels and process large numbers of cells to identify unique subpopulations.1
MFC requires >10 000 cells to establish proper gating thresholds and compensate for 
channel cross-talk before identifying clusters of cells with similar fluorescence intensities. 
Thus, MFC is difficult to use for low-abundance-cell analyses when the total available cell 
count is sample-limited (<10 000) and a suitable matrix is unavailable for initial 
optimization. Further, the poor spectral resolution from the bandpass filters yields an 
inherent risk that biological “noise”, such as abnormal autofluorescence from apoptotic 
cells,2,3 can cause misclassification.1 Fluorescence microscopy obviates such 
misclassification by using morphological localization of fluorescence signatures but requires 
lengthy manual cell counting, limiting clinical throughput for samples with >100 cells. 
Imaging flow cytometers (IFCs), such as the ImageStream, can acquire high-resolution, 
multispectral images of flowing cells.4-7 However, IFCs are costly and routine clinical 
processing remains limited by semiautomated data analysis.
Herein, we detail an SFC technology that can analyze cells within a range of 100–10 000 
cells/sample, which can be problematic for microscopy and MFC, and provides absolute 
quantitation of immunofluorescence and autofluorescence signatures. SFC shares the 
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hydrodynamic-sheathing and laser-excitation strategy with MFC, but fluorescence is 
spectrally dispersed onto a multichannel detector. This yields higher spectral resolution (0.7 
nm/pixel herein) that can be deconvoluted, enabling the use of multiple fluorophores with 
considerable spectral overlap while also discriminating contributions from autofluorescence.
3,8-12 Commercial SFC instruments from Cytek (Aurora) and Sony (SP6800) are available 
with the highest resolution provided by Sony, where a series of prisms disperses 
fluorescence onto a 32-channel PMT array (500–800 nm, 9.4 nm resolution).3,9,13 Nolan’s 
lab pioneered the use of a diffraction-grating spectrograph and CCD with high resolution 
(0.4 nm/pixel),12 but this resolution was countered by the operating mode of the CCD 
(snapshot mode).10-12 The CCD’s duty cycle, the percent of time the sensor was actively 
imaging, was low (~0.1%) because of the short exposure times (~10 μs) and extended 
readout times (~10 ms).12 Thus, there is high probability that cells would not be detected 
while the shutter is closed, which can be problematic for applications requiring the analysis 
of low-abundance cells.14
Our SFC system operates the CCD sensor in time-delayed-integration mode (TDI-SFC).7,15 
TDI-SFC utilizes microfluidic cell sheathing, 488 nm laser epi-illumination, and a 
spectrograph that disperses fluorescence along the columns of a CCD pixel array, providing 
an image of the cell’s emission spectrum that is confined to a few rows of the CCD (Figure 
1). As the cell moves through the field of view, the spectrum is shifted toward the serial 
register at a rate matching the cell’s linear velocity (i.e., synchronization). When the cell 
exits the field of view, the integrated emission spectrum is delivered to the CCD’s serial 
register for readout. As such, the CCD’s shutter is never closed, and the duty cycle is limited 
by the time required to shuttle photoelectrons between rows of the CCD array (30 μs duty 
cycle = 99%).
The coupling of SFC with TDI provides three main advantages: (i) signal integration along 
N rows of the CCD improves the SNR by N compared with a full-frame readout;15 (ii) the 
CCD’s shutter is never closed, with a duty cycle approaching 100%; and (iii) multiple cells 
occupying the field of view can be resolved by the TDI readout. TDI-SFC uses TDI to 
ensure that moving cells are detected with high sensitivity but trades morphological 
resolution for high spectral resolution and automated analysis by spectral unmixing.3,8-12 
Because of its simplicity, multiplexing capabilities, and high duty cycle, TDI-SFC is 
amenable to high-volume clinical sampling of low-abundance cells, such as circulating 
tumor cells16-19 and circulating leukemia cells (CLCs)20 enriched from blood-based liquid 
biopsies.14
As an example of the need for immunophenotyping low-abundance cells, acute leukemias 
are characterized by patients in remission that may harbor drug resistance. The disease can 
progress from low MRD (i.e., measurable residual disease) to lethal levels in weeks to 
months.21,22 MFC is commonly implemented for MRD analysis and identifies leukemic 
cells in bone-marrow aspirates23 by abnormal expression of hematopoietic membrane 
proteins.24 MFC’s clinical sensitivity (10−3 to 10−4) suffers when attempting to analyze 
leukemia cells in peripheral blood for MRD monitoring because of the high background of 
blood cells and low abundance of CLCs.25 Thus, standard-of-care MRD monitoring requires 
invasive biopsies of the bone marrow, where leukemic cells are more concentrated, and is 
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limited to testing once every few months. However, rapid relapse in acute leukemias requires 
weekly sampling to begin therapeutic intervention early and potentially improve patient 
outcome.22
We recently demonstrated a microfluidic assay to affinity-enrich CLCs from the peripheral 
blood of patients with acute myeloid leukemia (AML).20 CLCs share surface markers with 
normal cells, but they differ by abnormal coexpression of leukemia-associated antigens. For 
AML, we coated microfluidic surfaces with antibodies that enriched myeloid cells from 
blood, and we then interrogated the entire fraction against abnormal secondary markers to 
identify CLCs.20 Depending on the patient’s disease state, we detected a wide range of CLC 
frequencies (0.3–98.3%), with total cell counts ranging from 10 to 100 000 cells/sample,20 
which made the assay problematic for immunophenotyping via MFC. Thus, we released 
cells from the microfluidic device for immunophenotyping by semiautomated fluorescence 
microscopy. This process required computer-automated imaging (>2 h per sample) and 
lengthy manual cell counting (10 min to >6 h, depending on cell number) to discriminate 
cytosolic autofluorescence signatures from immunostaining fluorescence localized to the 
cell membrane.20
In this manuscript, we report the analytical figures of merit of this unique TDI-SFC system 
to determine its potential for immunophenotyping low-abundance cells.14 This was 
accomplished using fluorescent beads to evaluate the ability to clock the CCD at a rate that 
was synchronized to the beads’ flow velocities. Several routes (Table 1) were then 
investigated to improve fluorescence sensitivity and achieve high SNR readout even for dim 
fluorescence signals. Finally, as a demonstration, the TDI-SFC was used to 
immunophenotype a B-ALL cell line (SUP-B15) immunostained against terminal 
deoxynucleotidyl transferase (TdT), an immature marker observed in 95.8% of B-ALL 
patients.26-28 These results provided proof-of-concept support for CLC enumeration by TDI-
SFC immunophenotyping, even when cell numbers were well below 10 000.
■ EXPERIMENTAL SECTION
Reagents and Materials.
Microfluidic devices were fabricated in poly(methyl methacrylate) (PMMA, Plaskolite). 
Connections between syringe pumps (PicoPlus, Harvard Apparatus) and microfluidic 
devices used PEEK Tubing (0.007–0.020” i.d., 1/32” o.d.; Idex Health and Science), Inner-
Lok union capillary connectors (Polymicro Technologies), and barbed socket Luer Lock 
fittings (3/32” i.d., McMaster-Carr). Reagents included formaldehyde (37%); phosphate-
buffered saline (PBS, pH 7.4); fluorescein isothiocyanate (FITC); 7-aminoactinomycin D (7-
AAD); In-Speck Green fluorescent calibration beads (505/515, 6 μm; smaller beads were not 
tested because the cells of interest are >6 μm in diameter) from Thermo Fisher Scientific; 
PE-, PE-Cy5-, PE-Cy7-, and PerCP-Cy5.5-conjugated streptavidin from Biolegend; FITC-
labeled mouse anti-human-TdT Ab from BD (clone E17-1519); sucrose from Fluka; 
Histopaque-1119; Triton X-100; Micro-90; reagent-grade isopropanol (IPA) from Sigma-
Aldrich; and anti-mouse-Fc-specific Ab-binding-capacity (ABC) beads from Bangs Lab.
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A 488 nm solid-state laser (54 mW, TEM00, 1/e2 = 1.3 mm, Vortran Laser Technology) 
served as the excitation source. The laser was expanded using a 21.2× Keplerian beam 
expander (planoconvex lenses, f = 3 mm and f = 63.5 mm; VIS 0° coated; Edmund Optics) 
or a 7.1 × Galilean beam expander (biconcave lens, f = −9 mm, and planoconvex lens, f = 
63.5 mm; −A and VIS 0° coated; Thorlabs and Edmund Optics). The beam was filtered 
using a 488/6 nm BrightLine bandpass filter (Semrock), and the beam wings were cut using 
an adjustable diaphragm (4.7 mm, Thorlabs). The filtered beam was focused (planoconvex 
lens, f = 105 mm; −A coated; Thorlabs) to the back focal plane of a microscope objective 
(10× Fluar, NA = 0.50, or 20× Fluar, NA = 0.75; Zeiss). Emission was collected via epi-
illumination, filtered through a 495 nm BrightLine dichroic beamsplitter and a 496/LP 
BrightLine edge filter (Semrock), and diverted to a CP200 spectrograph (Jovin Yvon) via 
silver mirrors (Thorlabs). Fluorescence spectra were transduced with a Spec 10-100B back-
illuminated CCD (1340 × 100 pixels, 20 μm, 16-bit; Princeton Instruments) controlled via 
the Scientific Instrument Tool Kit for LabVIEW (R-Cubed Software). A focusing camera 
(MU503 RGB CMOS camera, AmScope) was inserted into the optical train via a kinematic 
mirror and a tube lens (f = 165 mm, −A coated; Thorlabs). All optics were assembled and 
mounted using cage cubes, lens tubes, and micrometer translational stages (Thorlabs) and 
were enclosed in a light-tight box. Power measurements were made with a S170C sensor 
(Thorlabs).
TDI-SFC Data Processing.
Spectral data were streamed from LabVIEW to TDMS files, and a custom MATLAB code 
converted the TDMS data, reconstructed spectral frames, and performed background 
subtraction with a smoothing spline fit to an average of ~2000 consecutive background 
frames. Frames without events were eliminated on the basis of a signal-to-background-noise 
threshold of 20 (beads) or 10 (cells). For multiplexed staining, emission spectra were 
unmixed by nonlinear curve-fitting from singly stained cells and autofluorescence in 
unstained cells (see the SI).
Microfluidic-Flow-Cell Fabrication.
A brass master mold was fabricated by high-precision micromilling (KERN 44, KERN 
Micro- and Feinwerktechnik) with carbide bits (Performance Micro Tool). Microfluidic 
devices were hot-embossed (P3H-15-CLX press, Wabash) into PMMA (upper platen, 
155 °C; lower platen, 80 °C; pressure, 1250 psi; 3 min molding; 102 °C demolding). Axel 
Plastics kindly gifted mold-release agent (MoldWiz F57-NC). Embossed devices were diced 
with a bandsaw; ports were drilled; and devices were cleaned with 10% Micro-90, IPA, and 
nanopure water. Microfluidic channels were enclosed with a cover plate (PMMA, 250 μm 
thick) using thermal-fusion bonding (105 °C, 2 h), and PEEK tubing was epoxied into the 
fluidic ports. Microchannel dimensions were measured before and after bonding by rapid 
laser-scanning confocal profilometry (VK-X250, Keyence). The flow cell was mounted to 
the TDI-SFC via a three-axis micrometer translational stage (Thorlabs) and connected to 
two syringe pumps, one driving sample (100 μL SGE syringe, 1.46 mm i.d.) and another 
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driving sheath flows (two 250 μL SGE syringes, 2.3 mm i.d.). Sample was introduced using 
a two-position, six-port, manual-injection valve with a 20 μL PEEK injection loop (Idex).
TDI-SFC Optimization.
For data without flow focusing, we processed InSpeck Green calibration beads (100% 
intensity) at 0.675μL/min (average 2 mm/s) in a square glass capillary (75 μm i.d., 
Polymicro) mounted to the TDI-SFC with a section burned to expose the imaged field of 
view. For all other data, we infused beads (~800 beads/μL in 15% sucrose/PBS) into the 
microfluidic device with 15% sucrose/PBS sheathing buffer.
Cell Culturing and Immunostaining.
SUP-B15 ALL cells (ATCC CRL-1929) were cultured at 37 °C with 5% CO2 in Iscove’s 
modified Dulbecco’s medium with 20% fetal-bovine serum (Gibco Laboratories) and 0.02 
μL/mL 2-mercaptoethanol (MP Biomedicals). Before and after staining, cells were washed 
with PBS (300g, 7 min) twice followed by resuspension in Histopaque-1119. For nuclear 
staining, cells were fixed with buffered 2% formaldehyde (15 min), permeabilized with 
0.1% Triton X-100 (10 min), and stained (40 min) with anti-TdT-FITC (10 μL per 106 cells 
in 200 μL) and/or 7-AAD (4 μM). Unstained cells were fixed and permeabilized.
Commercial MFC.
Cells and beads were processed at 35 μL/min (16 μm core) with an Accuri C6 Plus MFC 
(BD, 488 nm excitation). To measure bead concentrations, 30 μL of bead suspensions were 
diluted 10× with water, vortexed, and immediately processed with intersample water 
measurements to confirm no carryover. Beads were gated on SFC–FSC and FITC before 
quantification.
Simulations.
Velocity profiles were simulated using COMSOL Multiphysics 5.2a. We simulated TDI 
readout with a custom simulation coded in Fortran 90 and compiled with GFortran 
(MinGW). See the SI for further details.
Statistical Analysis.
Data sets were non-normal (Shapiro–Wilk normality testing) and were compared by 
Wilcoxon rank sums and signed rank testing with R Studio v1.0.153 and R v3.5.1. Reported 
medians include all data. Box plot outliers were outside the upper and lower quartiles ± 
interquartile ranges.
■RESULTS AND DISCUSSION
Optical Design of TDI-SFC.
For excitation (Figure 1A, blue), we expanded a 488 nm laser beam (54 mW, spectrally 
filtered 488/6 nm) and focused it to the back focal plane of an infinity-corrected microscope 
objective (10×, 0.50 NA, or 20×, 0.75 NA) for widefield epi-illumination. Two different 
beam expanders were evaluated (21.2× and 7.1×) to determine optimal illumination. In 
Hu et al. Page 6













either case, we eliminated the wings of the laser’s Gaussian intensity profile with a circular 
aperture to provide uniform illumination in the sensor’s field of view (FOV, Köhler epi-
illumination). With the 21.2× beam expander, we measured 4 mW (10.7 mW/cm2) excitation 
through the microscope objective. The 7.1× expander increased the power to 21 mW (56.1 
mW/cm2) but with less-uniform flux (the power-density relative standard deviation, RSD, 
increased from 2 to 15%, Figure S1).
The fluorescence emission (Figure 1A, yellow) was collected using the same microscope 
objective and was split from the excitation path via a dichroic mirror (DC). The emission 
was filtered (496 LP) before an f-matched lens was used to focus the image onto a 
spectrograph’s diffraction grating, which projected the dispersed emission along one axis of 
a back-illuminated CCD (spectral axis, 1340 pixels; spatial axis, 100 pixels; Figure 1B). We 
verified the spectrograph’s resolution (0.7 nm/pixel) over a wide wavelength range (500–
1000 nm) by feeding light from a monochromator into the TDI-SFC with a fiber-optic cable 
(Figure 1C). We also included a removable mirror to bypass the TDI-SFC emission optics 
and reconstruct the image onto a CMOS camera via a tube lens (Figure 1A, focus system). 
After alignment, the mirror was removed to enable TDI-SFC.
Principle of TDI Synchronization.
Cells were hydrodynamically focused with velocity vcell through the FOV, which spanned a 
distance of LFOV. During the transit time (tcell = LFOV/vcell), the cell’s fluorescence 
spectrum moved along Nrows of the CCD (Figure 1B). In tandem with the cell’s movement, 
the transduced-pixel-photogenerated charges were shifted down the CCD’s rows and toward 
the serial register. A delay time (tdelay) between each shift was clocked to synchronize the 
integration time (tint) with the cell’s transit time: tint = tdelay × Nrows = tcell.
When synchronized, the cell velocity matches the CCD’s clocking rate, and the fluorescence 
spectrum is confined to a few serial register reads. If the image resolution is 6 μm/pixel and a 
perfectly tracked cell (6 μm) enters the FOV exactly when the register shift starts, only one 
serial register read will produce the resultant cell or bead spectrum. However, if a cell does 
not enter the FOV exactly when the shift occurs, the collected signal will be contained in a 
few readouts, and if a cell moves faster or slower than the CCD’s clocking rate, the spectrum 
will “slur” over multiple readouts. We show this effect in Figures 2 and S2. Mismatching 
between cell velocity and the TDI clocking rate causes the CCD to readout fluorescence 
over longer time durations. Rather than showing a peak in the signal, the signal decreases in 
amplitude and broadens in time.
Critical to synchronization of the CCD’s TDI clocking rate, cell velocity must be constant 
throughout the flow cell’s cross-section. The maximum clocking rate is determined by the 
serial-register-readout time. We measured the readout time for the analogue-to-digital 
conversion of a serial register read using our CCD, which set a minimum tdelay of 2 ms. 
Therefore, the minimum integration time was 200 ms over the CCD’s 100 rows. We also 
measured the length of the TDI-CCD’s FOV with a 10μm objective (393 μm, 3.93 μm/pixel). 
Thus, the maximum linear velocity of a cell we could properly synchronize to the CCD 
would be 393 μm/200 ms ≈ 2 mm/s at 10× magnification and 197 μm/200 ms ≈ 1 mm/s at 
20× magnification. For slower velocities, we could increase the delay time for longer 
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integration times and increase the signal but also lower the throughput. Alternatively, a CCD 
with a faster readout (<2 ms) could enable higher velocities and, thus, higher throughput but 
with decreased integration times and signals.
Metrics for TDI-SFC Optimization.
We optimized the analytical figures of merit of the TDI-SFC using calibration beads (d = 6 
μm) with relative fluorescence intensities from 0.3 to 100%. Comparing the fluorescence of 
these beads to the fluorescence intensities of the Ab-binding-capacity (ABC) beads, we 
found that 0.3 to 100% intensity corresponded to loads of 3.8 ± 0.2 × 105 to 1.3 ± 0.1 × 108 
fluorescent Abs (Figure S3). Because immunolabeled surface antigens typically yield 103 to 
107 Abs per biological cell, we aimed to achieve high sensitivity for the dimmest beads 
(0.3% intensity). Next, we will describe sequential improvements made to the TDI-SFC 
(Table 1) before we applied the optimized system to immunophenotyping biological cells.
A cell or bead will generate a TDI signal S(λ, t) that is a fluorescence spectrum (λ) read 
over a certain time duration (Δt). With high synchronization between cell velocity and CCD 
clocking, the fluorescence peak signal will be maximized, and Δt will be minimized (Figure 
S2). Thus, for variables affecting TDI synchronization, we monitored Δt and the peak signal, 
Speak, at the maximum emission wavelength, λmax:
Speak = max[S(λmax, t)] (1)
For variables affecting the system’s fluorescence sensitivity, we integrated the signal (Sint) 






To calculate the SNR for each event, we divided Sint by the signal noise. We accounted for 
dark noise, read noise, and shot noise by fitting the time-integrated spectrum with a 
smoothing spline function, Ffit(λ) (Figure S4), and calculated noise from the square root of 





∑ [∑t S(λ, t) − Ffit(λ)]2
(3)
1D Microfluidic Focusing for Improved TDI Synchronization.
Hydrodynamic flow through a capillary or microchannel yields a laminar flow profile with 
nonuniform velocities, which can cause variable TDI synchronization from cell-to-cell. We 
observed this effect by flowing fluorescent beads through a 75 μm glass capillary at 2 mm/s 
(200 ms integration). In all cases, we verified the TDI-SFC focal plane was at the center of 
the capillary or microchannel using the focusing system and a micrometer sample mount. 
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We counted TDI signals when Speak increased 20× above background noise and analyzed 
events for Δt and Speak at the bead’s λmax (515 nm). In unfocused flow, TDI signals ranged 
from 56 to 112 ms in duration (interquartile range, median of 77 ms), and many events 
exhibited flat and non-Gaussian signal shapes (Figure 3A).
To improve velocity uniformity, we introduced the sample into a microfluidic flow cell with 
a T-junction, where merging of sheath buffer on either side of the sample provided 1D 
focusing along the x-direction of the flow cell. This restricted the sample’s lateral position, 
improving velocity uniformity in the sample stream’s cross-section (Figure S5). Without 
synchronizing CCD clocking to bead velocity (maximum of 2.4 mm/s), we observed more 
uniform event durations between 56 and 72 ms (interquartile range, median of 62 ms, Figure 
3B) with peak shapes characteristic of TDI synchronization (Figure 3A). Indeed, the median 
Speak increased by 4.6× with 1D focusing (Figure 3C).
We optimized flow conditions for 1D focusing by maintaining sample flow rate and 
increasing sheathing flow rate. The maximum velocity in the sample stream increased from 
1.41 to 2.11 mm/s, whereas the sample stream width decreased from 24 to 16.4 μm (Figure 
S5). A constant integration time of 200 ms was maintained, and we observed an optimal 
velocity of 1.83 mm/s that maximized Speak (median = 13 430 counts) and minimized Δt 
(median = 36 ms) with statistically significant differences (p < 10−4, Figure 4). These trends 
agreed within 10% of the theoretical calculations above and illustrated improvements in TDI 
synchronization with 1D focusing.
We note that the TDI-SFC optics do not include a confocal pinhole to block out-of-focus 
fluorescence. Cells not focused along the microchannel’s 92 μm depth can be detected but 
with a decreased, out-of-focus signal (Figure S6) and variable velocity and synchronization. 
In future work, we will employ 2D focusing to improve upon the gains made by 1D 
microfluidic focusing herein.
Improved TDI-SFC Sensitivity for Weak Fluorescence Signals.
The above experiments to optimize TDI synchronization used 100% relative intensity beads 
corresponding to a load of 108 fluorescent Abs (Figure S3). For dimmer beads, we sought to 
increase TDI-SFC sensitivity.
We first increased the excitation power from 4 to 21 mW. The signal from the 100% 
intensity beads at λmax increased beyond the CCD’s dynamic range (Figure 5A). Hence, we 
evaluated Sint at 550 nm, where the CCD was not saturated. We observed a 9.8× increase in 
Sint (5.2 × 106 to 4.7 × 107counts for 4 to 21 mW).
With increased excitation power, we analyzed Sint for dimmer beads with relative intensities 
of 0.3 to 10% (corresponding to 3.8 × 105 to 5.0 × 106 Abs) using the 10× objective (0.50 
NA). We observed a linear increase (R2 = 0.99) in the median Sint from 1.0 × 105 to 8.3 × 
106 counts for 0.3 to 10% intensities (Figure 5B) and a 152 SNR (median) for the dimmest 
(0.3% intensity) beads (Figure 5C).
We repeated these experiments using the 20× objective with higher NA (0.75) to increase the 
amount of fluorescence emission collected. We observed a substantial increase in signal 
Hu et al. Page 9













(Figure S7A) and could not analyze the 10% intensity beads because of CCD saturation. For 
0.3–3% intensity beads, the median Sint and SNR values increased by 7.5–10.2× and 4.0–
4.8×, respectively (Figure 5B). The dimmest (0.3%) beads produced a median Sint of 1.1 × 
106 counts at an SNR of 610 (Figure 5C), and Sint increased linearly with intensity (R2 = 
0.99) to 1820 SNR for the 3% intensity beads.
The data showed substantial gains in sensitivity using a higher NA objective for the 
fluorescent beads but at a reduced sample processing rate (i.e., throughput). Increasing the 
NA of the collection optics reduced the length of the FOV by a factor of 2. Given a constant 
integration time (200 ms), we reduced all flow rates by 1/2 (0.92 mm/s) to maintain an 
optimal velocity for TDI synchronization. In a similar manner, we halved bead velocity as 
we doubled the integration time to 400 ms (Figures 4D and S7B), but the 1.97× increase in 
Sint resulted in only a minimal change in SNR (p = 0.071). Thus, to immunophenotype cells 
in later experiments, we chose to use the 20× objective (0.75 NA), 200 ms of integration 
time, and 21 mW excitation power.
TDI-SFC Detection Efficiency and Throughput.
To evaluate detection efficiency, we processed different concentrations of fluorescent beads 
ranging between 200 and 1500 beads/μL (3% intensity beads). We measured bead 
concentration via the number of beads detected and the sample volume processed and 
correlated results to a commercial MFC (BD Accuri C6 Plus). From 200 to 750 beads/μL, 
we observed high concordance (R2 = 0.97) between the two systems with an average 
detection efficiency of 95% for TDI-SFC (Figure 6). We note there is no inherent limit for 
lower bead concentrations; we designed these experiments to test the upper limit of 
throughput.
At concentrations above 750 beads/μL, TDI-SFC detection efficiency decreased, and the 
number of detected events plateaued. Upon inspection of TDI signals, many events 
contained multiple, unresolved beads overlapping in time (Figure 6). This indicated a 
throughput of 90 beads/min (750 beads/μL) for the current TDI-SFC system, which was 
limited by the maximum clocking rate of our CCD sensor.
As TDI should be capable of resolving coincident events, we aimed to estimate multiple 
occupancy in the TDI-SFC detection volume. On the basis of Poisson statistics, we 
calculated the probability of coincident events (Figure S8) to be 1, 10, and 27% for 200, 750, 
and 1500 beads/μL, respectively. Above 10% occupancy, beads with varying velocities can 
produce slurring from imperfect synchronization and can overlap (Figure 6), highlighting 
that the current 1D-microfluidic-focusing strategy does not focus events along the z-
direction (Figure 1A). Variability in the focal position also affects the consistency in beads’ 
fluorescence intensities (Figure S6). This can increase the coefficient of variation (CV) for a 
single bead population. The mean fluorescence intensity (MFI) divided by the standard 
deviation indicated a 6.1% CV for the commercial MFC. For TDI-SFC, the CV was 
calculated using the interquartile range divided by the median, which compensated for non-
Gaussian statistics due to slurring. Slurring can skew Sint because slower beads reside in the 
FOV longer and yield higher time-integrated signals despite lower peak signals (Figure 
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S2B). By this definition, MFC had a 7.4% CV compared with a 27.8% CV in Sint for TDI-
SFC (Figure S9).
Multiplexed Detection of a Model B-ALL Cell Line (SUP-B15).
To monitor MRD for B-ALL, we can use microfluidic enrichment20 to purify and release 
CD19(+) B-cells; then identify all B-cells by a nuclear stain; and differentiate CLCs by 
positive immunostaining for TdT, a nontemplated polymerase found in the nuclei of CLCs 
from B-cells of patients with a leukemic phenotype.26 Although we used TdT as a leukemia-
cell identifier in this demonstration, other markers can be used as well to identify leukemia 
cells in B-ALL, such as CD10 and CD34. Toward these efforts, we sought to evaluate the 
spectral properties of the B-ALL cell line (SUP-B15) immunostained with TdT and a 
nuclear marker and determine the magnitude of TDI-SFC signals and SNR values for 
biological-cell identification.
We chose 7-AAD as a nuclear stain for TDI-SFC because of its large Stokes shift (λmax = 
647 nm), which enables multiplexing with dyes such as FITC, PE, or tandem dyes. Figure 
S10 demonstrates the multiplexing capabilities of TDI-SFC by analyzing mixtures of FITC 
and streptavidin conjugated with PE, PE-Cy5, PE-Cy7, or PerCP-Cy5.5. Classic-least-
squares (CLS) unmixing8 deconvoluted the resultant spectra into individual components, and 
we correctly identified 11 different dye mixtures (100% identification efficiency).
As surrogates for CLCs, we stained a model B-ALL cell line (SUP-B15) with the 7-AAD 
nuclear stain and a FITC-conjugated anti-TdT Ab. A third autofluorescent component was 
seen in this cell line, which we consistently observed in ~6% of SUP-B15 cells throughout 
normal culture, even in unstained cells (Figure S11). Previously, we differentiated such cells, 
which are likely apoptotic,2 by localization of the fluorescence signal; strong 
autofluorescence was observed throughout the cell cytoplasm rather than being confined to 
the nucleus or membrane.20 Rather than morphological examination by microscopy or IFC,5 
TDI-SFC can use high spectral resolution to differentiate FITC and 7-AAD emission from 
this autofluorescent signal.
To evaluate the spectral properties of the fluorescent components, we processed SUP-B15 
cells that were fixed, permeabilized, and either unstained (autofluorescence) or stained with 
7-AAD or anti-TdT-FITC Abs (Figure 7A). The experimental TDI-SFC emission spectra 
from singly stained cells matched reference spectra (Figure S12) and formed an initial 
training set for spectral unmixing, which did not need to be repeated as the fluorescent dye’s 
spectral properties remained constant. CLS unmixing8 could not compensate for slight 
shifting of the emission spectra with variation in the cells’ x-axis lateral positions (Figure 
S5C). Thus, we fit each emission spectrum with multiple Gaussian functions and used a 
nonlinear-least-squares solver with strict constraints (Table S2) to discern multiplexed 
fluorescence components.
We excluded highly autofluorescent SUP-B15 cells (Figure S13) and differentiated model 
normal B-cells (SUP-B15 cells stained with 7-AAD only) from model CLCs (SUP-B15 cells 
stained positive for both 7-AAD and anti-TdT-FITC Abs). Because classification was based 
on multiplexed unmixing of each cell’s unique fluorescence spectrum, TDI-SFC achieved 
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high accuracy in classifying cells, even at low cell numbers (46–111 cells per group) that 
would be prohibitive for traditional MFC. TDI-SFC identified 100% of cells as singly 
stained and correctly identified 99.1% of the model CLCs as positive for both markers 
(Figure 7B). These results were obtained with high median Sint signals for 7-AAD (1.7 × 
105 counts) and anti-TdT-FITC Abs (1.1 × 105 counts) with equal SNR (175, Figure 7C). 
However, we did observe some SUP-B15 cells stained only with anti-TdT-FITC that 
exhibited 7-AAD signal (Pearson’s correlation coefficient, r = 0.65) but not vice versa (r = 
0.06). Manual inspection of these events suggested that either slight errors in the FITC 
reference spectrum or too-relaxed fitting constraints led the unmixing algorithm to minimize 
error by assigning some FITC signal to 7-AAD. This demonstrates the importance of 
improving lateral focusing (Figure S5) in addition to providing 2-D focusing with future 
TDI-SFC microfluidic flow cells. These future efforts will further enable simpler CLS 
unmixing that can be conducted in real time.
■ CONCLUSIONS
We report a unique TDI-SFC system for the immunophenotyping of low-abundance 
biological cells. CCD readout of high-resolution fluorescence spectra was conducted in TDI 
mode with the sensor duty cycle approaching 100% and a high SNR readout, even for weak 
fluorescence signals. These attributes ensure that low-abundance cells were detected with 
95% efficiency, and for each cell, TDI-SFC acquired the entire fluorescence spectrum. This 
allowed for spectral unmixing and quantitative analysis of fluorescence signatures, which 
led to automated signal processing and obviated the need for thresholding, gating, and 
cluster analysis, as are typically done in conventional MFC and requires >10 000 events.
TDI-SFC will be particularly attractive for enumerating low-abundance cells, such as CLCs 
for acute-leukemia-MRD monitoring, via immunophenotyping. Because the affinity agent 
used to enrich CLCs from peripheral blood also selects cells that are not leukemic, 
immunophenotyping is critical for positively identifying CLCs. The workflow for MRD 
studies that enrich CLCs from leukemia patients’ blood has been challenged by the total 
number of cells enriched (spanning 100–100 000 cells).20 The range of total cell counts and 
CLC frequencies (0.3–98.3%), varying with the patient’s disease state, makes MFC and 
fluorescence microscopy operationally difficult in clinical settings because of the low 
number of target cells and the semiautomated nature of the enumeration process, 
respectively. An additional advantage of TDI-SFC or any flow cytometer for that matter is 
that it can include a flow-sorter unit to allow collection of the immunophenotyped CLCs. 
This negates the need for laser-capture microdissection or single-cell picking for recovery of 
CLCs, as would be required for microscopy.
We demonstrated the utility of TDI-SFC with ~100% classification accuracy for a B-ALL 
cell line stained with a nuclear dye (7-AAD) and a leukemic marker (anti-TdT-FITC). This 
was achieved by reading spectra with high signals (~106 integrated counts) and SNR (~175) 
generated by a TDI operation followed by SFC deconvolution for CLC identification even at 
low cell numbers (46–111 cells) that would be problematic for traditional MFC. Critical to 
these achievements were gains in TDI synchronization using a 1D microfluidic flow cell and 
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in the fluorescence sensitivity by increasing excitation power and the epi-illumination 
objective’s NA.
There were some limitations associated with the current TDI-SFC system. The relatively 
modest throughput, 90 events/min, was a result of the limited readout rate of the CCD; faster 
serial-register-readout rates can improve this as long as integration times provide sufficiently 
high SNR readout. Second, the CV of TDI-SFC was 27.8% (using only 1D flow focusing) 
compared with 6.1% for commercial MFC. Future renditions of the TDI-SFC will seek to 
use 2D microfluidic focusing to reproducibly position cells in the focal plane of the epi-
illumination objective for more uniform velocity and fluorescence-collection efficiency, 
which will significantly lower the CV. These improvements in flow focusing can also be 
made to more precisely align cells laterally, minimizing shifts in the emission spectra from 
cell to cell and enabling traditional, real-time, classical-least-squares unmixing.
After further optimization of the TD-SFC system as noted above, we will seek to integrate 
the TDI-SFC system with a microfluidic for the affinity purification of CLCs directly from 
peripheral blood for monitoring MRD in pediatric B-ALL patients.20 Specifically, we will 
seek to enrich CD19+ cells from blood and evaluate multiplexed immunostaining against 
TdT as well as CD10 and CD34 markers to identify the CLCs from the enriched CD19+ cell 
population. We will compare TDI-SFC analysis with those of conventional microscopy and 
MFC systems, where TDI-SFC’s enhanced spectral resolution will provide additional 
confidence in calling low-abundance cells when total cell counts are sample-limited. Further, 
the microfluidic approach for flow focusing presented herein will enable direct integration18 
of affinity-purification devices with the TDI-SFC system. This will help to eliminate transfer 
losses of low-abundance cells, including circulating tumor cells and other low-abundance-
cell types, such as CLCs.16-19
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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(A) Picture and optical diagram of the TDI-SFC. A beam expander and epi-illumination lens 
produced widefield excitation in the flow cell from the 488 nm laser. Fluorescence emission 
was filtered and passed to a spectrograph that spectrally dispersed and focused the emission 
onto a back-illuminated CCD. If engaged, a removable mirror provided imaging for system 
focusing using a CMOS camera. (B) Illustration of TDI mode. The CCD’s delay time, which 
sets the shift rate, is matched with the cell’s velocity through the flow cell, providing 
integrated readout of the cell’s fluorescence. (C) Cell’s fluorescence spectrally resolved via 
the spectrograph.
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Theoretical TDI-peak shapes for varying synchronization between cell velocity and CCD 
delay time. A relative velocity of 1 represents perfect synchronization.
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(A) TDI imaging of fluorescent beads (100% intensity) without focusing (red) and with 1D 
microfluidic focusing (blue): spectra acquired over 2 s with background data between events 
removed, a bead spectrum, and the signal at λmax (515 nm) over time. (B,C) Box plots of 
(B) Δt and (C) Speak. The middle line shows the median; box edges show the lower and 
upper quartiles; the bars show minima and maxima, excluding outliers; the squares show 
averages; and the dots represent all the data. Statistical analyses demonstrated significance at 
p < 10−2 (*) and p < 10−4 (**). Sample and sheath flow rates were 0.178 and 0.217 μL/min, 
respectively, with the 10× objective and 4 mW excitation.
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Optimization of TDI synchronization in the 1D microfluidic flow cell, showing box plots of 
Δt (red) and Speak (blue) values at varying maximum velocities. Data were acquired with a 
10× objective and 4 mW excitation. Statistical analyses showed p < 10−4 (**).
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(A) Signals for 100% intensity beads at 4–21 mW excitation. (B,C) Box plots of (B) Sint and 
(C) SNR for 0.3–10% beads at 10× (0.50 NA) or 20× (0.75 NA) and 21 mW. (D) Box plots 
for 400 ms integration of 3% beads at 10×. Unless noted otherwise, statistical analysis 
showed p < 10−6.
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TDI-SFC measurement of bead concentration (3% intensity, 10× objective, 21 mW, 200 ms 
integration) compared with that of a commercial MFC instrument. TDI-SFC detection 
efficiency compared with that of commercial MFC (left). Coincident beads not resolved (red 
stars) at high bead concentrations (right).
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(A) Integrated spectra of unstained (autofluorescence) SUP-B15 cells or cells stained with 
anti-TdT-FITC or 7-AAD. Fit curves (color lines) are overlaid on data (black lines). (B) 
Multiplexed unmixing of SUP-B15 cells stained with anti-TdT-FITC only, 7-AAD only 
(model B-cells), or both markers (model CLCs). Data without signal was expanded near the 
axis for illustration purposes only. (C) Box plots of Sint and SNR for 7-AAD and anti-TdT-
FITC staining. Statistical analysis showed p < 10−4 (**).
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Table 1.
Variables Tested for TDI-SFC to Improve TDI Synchronization and Fluorescence Sensitivity
TDI-SFC
variable range improvement figure
cell focusing none → 1D focusing synchronization:4.5 × Speak,0.8× Δt 3
cell velocity 1.41 → 1.83 ← 2.11 mm/s synchronization: 2.3 × Speak, 0.5× Δt 4
excitation power 4 → 21 mW sensitivity: >9× Sint 5A
objective NA 0.5 → 0.75 NA sensitivity: 8–10× Sint, 4× SNR 5B,C
TDI-integration time 200 → 400 ms sensitivity: 2× Sint, 1 × SNR 5D
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